Cambridge Investment Research Advisors, Inc.
Position in ACRS — Aclaris Therapeutics, Inc.
CIK 1419186
FAIRFIELD, IA
Position in ACRS
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$157,023
+$30,986 QoQ
Shares Held
41,873
0.0% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Cambridge Investment Research Advisors, Inc. holds $50,208,596 across 75 Biotechnology names. ACRS ranks #45 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,955 | $7,124,545 | |
| 2 | EXEL |
Exelixis, Inc.
|
159,749 | $6,851,634 | |
| 3 | NKTR |
Nektar Therapeutics
|
56,055 | $4,033,157 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,832 | $3,733,396 | |
| 5 | IBRX |
ImmunityBio, Inc.
|
284,704 | $2,183,679 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
29,059 | $2,157,921 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
37,992 | $1,807,279 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
42,754 | $1,723,413 |
All Filings in ACRS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $157,023 | 41,873 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $126,037 | 41,873 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $79,558 | 41,873 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $59,459 | 41,873 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $64,065 | 41,873 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $103,845 | 41,873 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $48,153 | 41,873 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $46,060 | 41,873 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $51,922 | 41,873 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $43,966 | 41,873 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $105,065 | 15,338 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $159,055 | 15,338 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $124,084 | 15,338 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $241,573 | 15,338 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $244,568 | 15,538 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $214,118 | 15,338 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $264,427 | 15,338 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $223,014 | 15,338 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $276,084 | 15,338 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $258,132 | 14,700 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $370,440 | 14,700 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $289,681 | 44,773 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $114,879 | 44,700 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $72,414 | 44,700 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $46,488 | 44,700 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||